Periodontal healing following reconstructive surgery: effect of guided tissue regeneration using a bioresorbable barrier device when combined with autogenous bone grafting. A randomized-controlled trial 10-year follow-up
- PMID: 20447260
- DOI: 10.1111/j.1600-051X.2010.01532.x
Periodontal healing following reconstructive surgery: effect of guided tissue regeneration using a bioresorbable barrier device when combined with autogenous bone grafting. A randomized-controlled trial 10-year follow-up
Abstract
Objective: The objective of this 10-year randomized-controlled trial follow-up was to evaluate the stability of treatment outcomes following the implantation of autogenous bone graft with or without guided tissue regeneration (GTR) in the treatment of deep intra-bony periodontal defects.
Materials and methods: Forty patients exhibiting deep intra-bony periodontal defects were included in a randomized-controlled trial evaluating the adjunctive effect of GTR to autogenous bone graft. Twenty-six of 39 patients completing the original study were available for follow-up 10 years post-treatment. The patients had been included in a structured maintenance programme and were evaluated using the criteria of the original study by the same investigators.
Results: Significant improvements in the probing depth and clinical attachment level were observed for both groups between baseline and 9 months. Whereas the autogenous bone graft+GTR group showed significant improvements in probing bone levels and increased gingival recession at 9 months, no significant differences were observed for the autogenous bone graft group. Nine-month within-group results were maintained throughout the 10-year follow-up. Nevertheless, between-group comparisons at 10 years showed that the autogenous bone graft+GTR group exhibited significantly greater probing depth reduction (mean +/- SE: 4.2 +/- 0.5 versus 2.7 +/- 0.5 mm, p=0.023) and probing bone-level gain (3.9 +/- 0.8 versus 1.3 +/- 0.9 mm, p=0.034) than the autogenous bone graft group. Borderline significant differences between the autogenous bone graft+GTR and the autogenous bone graft groups were observed for clinical attachment level gain at 10 years (3.8 +/- 0.5 versus 2.2 +/- 0.7 mm, p=0.067), whereas no significant differences were observed for gingival recession (0.7 +/- 0.3 versus 0.6 +/- 0.5 mm, p>0.05).
Conclusions: The results of this randomized study suggest that statistically significant differences were found with the adjunct use of GTR to an autogenous bone graft at 10 years. Nevertheless, these results should be interpreted with caution in light of its clinical relevance and biological rationale. Importantly, resolution of deep intra-bony periodontal defects can be maintained in the presence of a structured maintenance programme emphasizing high oral hygiene standards.
Similar articles
-
Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.J Periodontol. 2010 Nov;81(11):1587-95. doi: 10.1902/jop.2010.100094. Epub 2010 Jun 28. J Periodontol. 2010. PMID: 20583915 Clinical Trial.
-
Periodontal healing following reconstructive surgery: effect of guided tissue regeneration using a bioresorbable barrier device when combined with autogenous bone grafting. A randomized controlled clinical trial.J Clin Periodontol. 2008 Jan;35(1):37-43. doi: 10.1111/j.1600-051X.2007.01160.x. J Clin Periodontol. 2008. PMID: 18173400 Clinical Trial.
-
Guided tissue regeneration for periodontal infra-bony defects.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001724. doi: 10.1002/14651858.CD001724.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 May 29;5:CD001724. doi: 10.1002/14651858.CD001724.pub3. PMID: 16625546 Updated. Review.
-
Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.J Periodontol. 2008 Apr;79(4):660-9. doi: 10.1902/jop.2008.070473. J Periodontol. 2008. PMID: 18380559 Clinical Trial.
-
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.Eur J Oral Implantol. 2009 Winter;2(4):247-66. Eur J Oral Implantol. 2009. PMID: 20467602 Review.
Cited by
-
A comparative clinico-radiographic study of guided tissue regeneration with bioresorbable membrane and a composite synthetic bone graft for the treatment of periodontal osseous defects.J Indian Soc Periodontol. 2015 Jul-Aug;19(4):416-23. doi: 10.4103/0972-124X.154544. J Indian Soc Periodontol. 2015. PMID: 26392691 Free PMC article.
-
Composite outcome measure (COM) and pocket closure as clinical endpoints following treatment of infra bony defects with Guided tissue regeneration and Open flap debridement.J Indian Soc Periodontol. 2022 Nov-Dec;26(6):570-576. doi: 10.4103/jisp.jisp_603_21. Epub 2022 Nov 14. J Indian Soc Periodontol. 2022. PMID: 36582948 Free PMC article.
-
Analysis of inflammatory periimplant lesions during a 12-week period of undisturbed plaque accumulation--a comparison between flapless and flap surgery in the mini-pig.Clin Oral Investig. 2012 Apr;16(2):379-85. doi: 10.1007/s00784-011-0546-7. Epub 2011 Mar 29. Clin Oral Investig. 2012. PMID: 22186942
-
A 5-year prospective study on regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft.Clin Oral Investig. 2018 Apr;22(3):1235-1242. doi: 10.1007/s00784-017-2208-x. Epub 2017 Sep 30. Clin Oral Investig. 2018. PMID: 28965250
-
Ten-Year Stability of Clinical Attachment after Regenerative Treatment of Infrabony Defects and Controls.J Clin Med. 2022 Jan 21;11(3):543. doi: 10.3390/jcm11030543. J Clin Med. 2022. PMID: 35159996 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical